ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12 janv. 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
31 mars 2022 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
04 oct. 2021 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product,...
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021
13 janv. 2021 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his...
ViaDerma, Inc. Provides a Corporate Update
23 juin 2020 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, June 23, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: ViaDerma has partnered with the Brewer Group, Inc., to...
ViaDerma, Inc. Provides a Corporate Update
16 janv. 2020 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 16, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: A new 55 ml spray bottle for use in hospitals has been...
ViaDerma Provides an Update to Shareholders via a Letter from the CEO
12 juil. 2018 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the...
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
02 avr. 2018 08h20 HE
|
ViaDerma, Inc.
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem. ViaDerma...
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
02 mars 2018 09h15 HE
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
02 mars 2015 09h17 HE
|
ViaDerma Licensing
LOS ANGELES, March 2, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start...